Literature DB >> 17145915

A public health perspective on research ethics.

D R Buchanan1, F G Miller.   

Abstract

Ethical guidelines for conducting clinical trials have historically been based on a perceived therapeutic obligation to treat and benefit the patient-participants. The origins of this ethical framework can be traced to the Hippocratic oath originally written to guide doctors in caring for their patients, where the overriding moral obligation of doctors is strictly to do what is best for the individual patient, irrespective of other social considerations. In contrast, although medicine focuses on the health of the person, public health is concerned with the health of the entire population, and thus, public health ethics is founded on the societal responsibility to protect and promote the health of the population as a whole. From a public health perspective, research ethics should be guided by giving due consideration to the risks and benefits to society in addition to the individual research participants. On the basis of a duty to protect the population as a whole, a fiduciary obligation to realise the social value of the research and the moral responsibility to distribute the benefits and burdens of research fairly across society, how a public health perspective on research ethics results in fundamental re-assessments of the proper course of action for two salient topical issues in research ethics is shown: stopping trials early for reasons of efficacy and the conduct of research on less expensive yet less effective interventions.

Entities:  

Mesh:

Year:  2006        PMID: 17145915      PMCID: PMC2563349          DOI: 10.1136/jme.2006.015891

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  24 in total

1.  Investigators' responsibilities for human subjects in developing countries.

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

2.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

3.  An ethics framework for public health.

Authors:  N E Kass
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

4.  Public health ethics: mapping the terrain.

Authors:  James F Childress; Ruth R Faden; Ruth D Gaare; Lawrence O Gostin; Jeffrey Kahn; Richard J Bonnie; Nancy E Kass; Anna C Mastroianni; Jonathan D Moreno; Phillip Nieburg
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

5.  What is not found in the spreadsheets.

Authors:  Herbert L Needleman
Journal:  Neurotoxicol Teratol       Date:  2002 Jul-Aug       Impact factor: 3.763

6.  Vioxx, the implosion of Merck, and aftershocks at the FDA.

Authors:  Richard Horton
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321

7.  Justice and fairness in the Kennedy Krieger Institute lead paint study: the ethics of public health research on less expensive, less effective interventions.

Authors:  David R Buchanan; Franklin G Miller
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

8.  The ethics of clinical research in the Third World.

Authors:  M Angell
Journal:  N Engl J Med       Date:  1997-09-18       Impact factor: 91.245

9.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

10.  Canaries in the mines: children, risk, non-therapeutic research, and justice.

Authors:  M Spriggs
Journal:  J Med Ethics       Date:  2004-04       Impact factor: 2.903

View more
  14 in total

Review 1.  Autonomy, paternalism, and justice: ethical priorities in public health.

Authors:  David R Buchanan
Journal:  Am J Public Health       Date:  2007-11-29       Impact factor: 9.308

2.  Ethical challenges in cluster randomized controlled trials: experiences from public health interventions in Africa and Asia.

Authors:  David Osrin; Kishwar Azad; Armida Fernandez; Dharma S Manandhar; Charles W Mwansambo; Prasanta Tripathy; Anthony M Costello
Journal:  Bull World Health Organ       Date:  2009-10       Impact factor: 9.408

3.  Risk-benefit analysis: from a logical point of view.

Authors:  Georg Spielthenner
Journal:  J Bioeth Inq       Date:  2012-03-21       Impact factor: 1.352

4.  FDA's Proposed Guidance for Laboratory Developed Tests: How Should Regulators Balance the Risks and Promise of Innovation in Clinical Genetics?

Authors:  Michelle Bayefsky; Benjamin E Berkman
Journal:  FDLIs Food Drug Policy Forum       Date:  2015-02-25

5.  Perioperative Rehabilitation in Operable Lung Cancer Patients (PROLUCA): A Feasibility Study.

Authors:  Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul Frost Clementsen; Jesper H Pedersen; Henning Langberg
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

6.  When communities are really in control: ethical issues surrounding community mobilisation for dengue prevention in Mexico and Nicaragua.

Authors:  Robert J Ledogar; Carlos Hernández-Alvarez; Amy C Morrison; Jorge Arosteguí; Arcadio Morales-Perez; Elizabeth Nava-Aguilera; José Legorreta-Soberanis; Dawn Caldwell; Josefina Coloma; Eva Harris; Neil Andersson
Journal:  BMC Public Health       Date:  2017-05-30       Impact factor: 3.295

7.  Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research.

Authors:  Louise-Anne McNutt; Elisa J Gordon; Anneli Uusküla
Journal:  BMC Med Ethics       Date:  2009-08-27       Impact factor: 2.652

Review 8.  Is "rescue" therapy ethical in randomized controlled trials?

Authors:  Richard Holubkov; J Michael Dean; John Berger; Kanwaljeet J S Anand; Joseph Carcillo; Kathleen Meert; Jerry Zimmerman; Christopher Newth; Rick Harrison; Douglas F Willson; Carol Nicholson
Journal:  Pediatr Crit Care Med       Date:  2009-07       Impact factor: 3.624

9.  Deception in research is morally problematic … and so too is not using it morally: reply to open peer commentaries on "the use of deception in public health behavioral intervention trials: a case study of three online alcohol trials".

Authors:  Jim McCambridge; Kypros Kypri; Preben Bendtsen; John Porter
Journal:  Am J Bioeth       Date:  2014       Impact factor: 11.229

10.  The use of deception in public health behavioral intervention trials: a case study of three online alcohol trials.

Authors:  Jim McCambridge; Kypros Kypri; Preben Bendtsen; John Porter
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.